Ultragenyx Pharmaceutical Inc. · NASDAQ:RARE
Huizenga Theodore Alan sold 161 Ultragenyx Pharmaceutical Inc. shares (Form 4)
Traded Sep 3, 2026 · Filed Sep 8, 2026
On Sep 3, 2026, Huizenga Theodore Alan (SVP, Chief Accounting Officer) sold 161 Ultragenyx Pharmaceutical Inc. shares at US$13.99 for US$2,252, leaving 69,146 shares. Filed Sep 8, 2026 (Form 4).
- Sold
- 161 shares
- Price
- US$13.99
- Value
- US$2,252
- Holding after
- 69,146 shares
- Trading plan
- No
- Role
- SVP, Chief Accounting Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 3, 2026 | Common Stock | Sale | 161 | US$13.99 | 69,146 | Direct |
Source
Related
- Ultragenyx Pharmaceutical Inc.
- Huizenga Theodore Alan
- Ultragenyx Pharmaceutical Inc. shareholders
- Form 4 · Huizenga Theodore Alan · Sep 15, 2026
- Form 4 · Huizenga Theodore Alan · Apr 24, 2026
- Schedule 13G · Madison Avenue Partners, LP · Oct 20, 2026
- Form 4 · Horn Howard · Oct 19, 2026
- Schedule 13G · Rtw Investments, LP · Aug 14, 2026
- Schedule 13G · AQR Capital Management LLC · Aug 13, 2026
- Schedule 13G · State Street Corp · Aug 7, 2026